10.04.2024
|
Access and user authorisation
Access and user authorisation
|
03.04.2024
|
Advanced Training ICP-MS
The practical training and further education of employees of the national quality control laboratories (QCLs) of African project partners is a focus of the GHPP LabTrain project.
|
15.04.2024
|
Agenda Iris User Group Meeting
Agenda Iris User Group Meeting
|
03.04.2024
|
Batch release applications
(PEI-C Rebuild)
Holder of marketing authorizations for medicinal products are able to submit batch release applications pursuant to section 32 of the German Medicinal Products Act (Arzneimittelgesetz) electronically by using this portal.
|
02.04.2024
|
BfArM Events
Announcement of the annual meeting fo the WHO Network für the System of International Classifications (WHO-FIC) 16-20 October 2023
|
25.01.2024
|
Biosimilar-fellows visit BfArM for the first time - South-South and North-South cooperation
Biosimilar-Fellows visit BfArM for the first time
|
25.03.2024
|
Capacity Development
Capacity Development
|
11.06.2024
|
CHMP Committee for Medicinal Products for Human Use
CHMP Meeting Highlights for May 2024
|
03.04.2024
|
CHMP Meeting Highlights April 2024
CHMP Meeting Highlights April 2024
|
20.12.2023
|
CHMP Meeting Highlights December 2023
CHMP Meeting Highlights December 2023
|
28.02.2024
|
CHMP Meeting Highlights February 2024
CHMP Meeting Highlights February 2024
|
09.02.2024
|
CHMP Meeting Highlights January 2024
CHMP Meeting Highlights January 2024
|
03.04.2024
|
CHMP Meeting Highlights March 2024
CHMP Meeting Highlights March 2024
|
10.06.2024
|
CHMP Meeting Highlights May 2024
CHMP Meeting Highlights May 2024
|
03.05.2024
|
Clinical trials
The Clinical Trials Database contains information on clinical trials with medicinal products authorised in Germany on the basis of Directive 2001/20/EC.
|
10.06.2024
|
Code-Search
Code-Search
|
10.06.2024
|
Code-Search: ICD-10-GM online
Code-Search
|
03.04.2024
|
Completion of the DQALab training series
On November 6, 2023, the third and final DQALab training started as part of the GHPP LabTrain project, which is carried out by the Federal Institute for Drugs and Medical Devices (BfArM) and the Institute for Pharmaceutical and Applied Analytics (InphA).
|
30.01.2024
|
Conditions of use of user self-administration
Conditions of use for user self-administration
|
16.02.2024
|
Contrast agents containing gadolinium: deposits in the brain and other tissues
Active substance: gadolinium
For contrast agents containing gadolinium, the suspension of marketing authorisations has been extended until 28 February 2026.
|